Koninklijke Philips NV (PHG)
26.63
-0.19
(-0.71%)
USD |
NYSE |
May 06, 12:22
Koninklijke Philips Enterprise Value: 29.74B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 29.74B |
| May 02, 2024 | 29.50B |
| May 01, 2024 | 29.68B |
| April 30, 2024 | 29.49B |
| April 29, 2024 | 29.64B |
| April 26, 2024 | 24.53B |
| April 25, 2024 | 24.21B |
| April 24, 2024 | 24.43B |
| April 23, 2024 | 24.47B |
| April 22, 2024 | 24.11B |
| April 19, 2024 | 23.54B |
| April 18, 2024 | 23.54B |
| April 17, 2024 | 23.69B |
| April 16, 2024 | 23.85B |
| April 15, 2024 | 23.93B |
| April 12, 2024 | 23.61B |
| April 11, 2024 | 24.10B |
| April 10, 2024 | 23.95B |
| April 09, 2024 | 24.14B |
| April 08, 2024 | 23.96B |
| April 05, 2024 | 23.63B |
| April 04, 2024 | 23.88B |
| April 03, 2024 | 23.94B |
| April 02, 2024 | 23.48B |
| April 01, 2024 | 23.40B |
| Date | Value |
|---|---|
| March 31, 2024 | 23.56B |
| March 28, 2024 | 23.56B |
| March 27, 2024 | 23.85B |
| March 26, 2024 | 23.59B |
| March 25, 2024 | 23.46B |
| March 22, 2024 | 23.56B |
| March 21, 2024 | 23.89B |
| March 20, 2024 | 24.11B |
| March 19, 2024 | 24.28B |
| March 18, 2024 | 24.16B |
| March 15, 2024 | 24.52B |
| March 14, 2024 | 24.87B |
| March 13, 2024 | 24.97B |
| March 12, 2024 | 24.78B |
| March 11, 2024 | 24.83B |
| March 08, 2024 | 24.32B |
| March 07, 2024 | 24.41B |
| March 06, 2024 | 23.93B |
| March 05, 2024 | 23.76B |
| March 04, 2024 | 23.86B |
| March 01, 2024 | 23.85B |
| February 29, 2024 | 23.60B |
| February 28, 2024 | 23.46B |
| February 27, 2024 | 23.71B |
| February 26, 2024 | 23.63B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
17.94B
Minimum
Nov 03 2022
59.68B
Maximum
Apr 23 2021
38.10B
Average
40.29B
Median
Enterprise Value Benchmarks
| Cardinal Health Inc | 26.23B |
| DaVita Inc | 22.27B |
| uniQure NV | -291.78M |
| ProQR Therapeutics NV | 36.81M |
| Merus NV | 2.467B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.085B |
| Revenue (Quarterly) | 4.495B |
| Total Expenses (Quarterly) | 5.389B |
| EPS Diluted (Quarterly) | -1.195 |
| Gross Profit Margin (Quarterly) | 43.86% |
| Profit Margin (Quarterly) | -24.14% |
| Earnings Yield | -3.63% |
| Normalized Earnings Yield | -3.589 |